Login / Signup

Performance of factor IX extended half-life product measurements in external quality control assessment programs.

Angelique NederlofSteve KitchenPiet MeijerMarjon CnossenNae Ali PourGeoffrey KershawIan JenningsIsobel WalkerMoniek P M de Maat
Published in: Journal of thrombosis and haemostasis : JTH (2020)
Large variation is observed in the measurement of FIX activity levels after administration of rFIX and EHL FIX products. For N9-GP, most silica-based assays show especially high levels. It is essential to standardize and improve reliability of measurements of these concentrates as diagnosis and treatment monitoring is based on these results.
Keyphrases
  • quality control
  • public health
  • high throughput
  • clinical evaluation